GLAXOSMITHKLINE, LLC: $279,862,800 Department of Defense Contract
:COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB
| Recipient | GLAXOSMITHKLINE, LLC |
|---|---|
| Awarding agency | Department of Defense |
| Awarding sub-agency | Department of the Army |
| Award amount | $279,862,800 |
| Contract type | DEFINITIVE CONTRACT |
| Description | :COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB |
| Start date | 2021-09-24 |
| Place of performance (state) | NC |
| Award ID | W58P0521C0008 |
| Official record | https://www.usaspending.gov/award/CONT_AWD_W58P0521C0008_9700_-NONE-_-NONE- |